212 related articles for article (PubMed ID: 10188872)
41. Comparison of nested competitive RT-PCR and real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21) positive acute myelogenous leukemia.
Wattjes MP; Krauter J; Nagel S; Heidenreich O; Ganser A; Heil G
Leukemia; 2000 Feb; 14(2):329-35. PubMed ID: 10673753
[TBL] [Abstract][Full Text] [Related]
42. Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO.
Fliegauf M; Stock M; Berg T; Lübbert M
Oncogene; 2004 Dec; 23(56):9070-81. PubMed ID: 15489901
[TBL] [Abstract][Full Text] [Related]
43. Transcription of the AML1/ETO chimera is guided by the P2 promoter of the AML1 gene in the Kasumi-1 cell line.
Markova EN; Kantidze OL; Razin SV
Gene; 2012 Dec; 510(2):142-6. PubMed ID: 22995345
[TBL] [Abstract][Full Text] [Related]
44. Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice.
Cuenco GM; Ren R
Oncogene; 2004 Jan; 23(2):569-79. PubMed ID: 14724585
[TBL] [Abstract][Full Text] [Related]
45. Common gene expression signatures in t(8;21)- and inv(16)-acute myeloid leukaemia.
Ichikawa H; Tanabe K; Mizushima H; Hayashi Y; Mizutani S; Ishii E; Hongo T; Kikuchi A; Satake M
Br J Haematol; 2006 Nov; 135(3):336-47. PubMed ID: 16989659
[TBL] [Abstract][Full Text] [Related]
46. A novel gene, FGA7, is fused to RUNX1/AML1 in a t(4;21)(q28;q22) in a patient with T-cell acute lymphoblastic leukemia.
Mikhail FM; Coignet L; Hatem N; Mourad ZI; Farawela HM; El Kaffash DM; Farahat N; Nucifora G
Genes Chromosomes Cancer; 2004 Feb; 39(2):110-8. PubMed ID: 14695990
[TBL] [Abstract][Full Text] [Related]
47. Identification of the novel AML1 fusion partner gene, LAF4, a fusion partner of MLL, in childhood T-cell acute lymphoblastic leukemia with t(2;21)(q11;q22) by bubble PCR method for cDNA.
Chinen Y; Taki T; Nishida K; Shimizu D; Okuda T; Yoshida N; Kobayashi C; Koike K; Tsuchida M; Hayashi Y; Taniwaki M
Oncogene; 2008 Apr; 27(15):2249-56. PubMed ID: 17968322
[TBL] [Abstract][Full Text] [Related]
48. An acute myeloid leukemia gene, AML1, regulates transcriptional activation and hemopoietic myeloid cell differentiation antagonistically by two alternative spliced forms.
Tanaka T; Tanaka K; Ogawa S; Kurokawa M; Mitani K; Yazaki Y; Shibata Y; Hirai H
Leukemia; 1997 Apr; 11 Suppl 3():299-302. PubMed ID: 9209372
[TBL] [Abstract][Full Text] [Related]
49. [Complex translocation (8;15;21) (q22;p12;q22) in a child with AML-M2 showing de novo appearance of the short form of AML1-MTG8 chimeric mRNA during the course].
Watanabe A; Koike K; Fukushima T; Izumi I; Ohba K; Tsuchida M
Rinsho Ketsueki; 2001 Feb; 42(2):110-4. PubMed ID: 11280916
[TBL] [Abstract][Full Text] [Related]
50. AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML.
Licht JD
Oncogene; 2001 Sep; 20(40):5660-79. PubMed ID: 11607817
[No Abstract] [Full Text] [Related]
51. Real-time quantitative reverse transcription-polymerase chain reaction for the detection of AML1-MTG8 fusion transcripts in t(8;21)-positive acute myelogenous leukemia.
Kondo M; Kudo K; Kimura H; Inaba J; Kato K; Kojima S; Matsuyama T; Horibe K
Leuk Res; 2000 Nov; 24(11):951-6. PubMed ID: 11086178
[TBL] [Abstract][Full Text] [Related]
52. ZFP36L2, a novel AML1 target gene, induces AML cells apoptosis and inhibits cell proliferation.
Liu J; Lu W; Liu S; Wang Y; Li S; Xu Y; Xing H; Tang K; Tian Z; Rao Q; Wang M; Wang J
Leuk Res; 2018 May; 68():15-21. PubMed ID: 29518627
[TBL] [Abstract][Full Text] [Related]
53. Ribonuclease H attack of leukaemic fused transcripts AML1-MTG8 (ETO) by DNA/RNA chimeric hammerhead ribozymes.
Kozu T; Sugio Y; Fukuyama T; Sueoka E; Otsuka T; Akagi K
Genes Cells; 2000 Aug; 5(8):637-47. PubMed ID: 10947849
[TBL] [Abstract][Full Text] [Related]
54. Potential involvement of the AML1-MTG8 fusion protein in the granulocytic maturation characteristic of the t(8;21) acute myelogenous leukemia revealed by microarray analysis.
Shimada H; Ichikawa H; Ohki M
Leukemia; 2002 May; 16(5):874-85. PubMed ID: 11986950
[TBL] [Abstract][Full Text] [Related]
55. G-CSF activates STAT pathways in Kasumi-1 myeloid leukemic cells with the t(8; 21) translocation: basis for potential therapeutic efficacy.
Da Silva N; Meyer-Monard S; Menot ML; Degos L; Baruchel A; Dombret H; Chomienne C
Cytokines Cell Mol Ther; 1997 Jun; 3(2):75-80. PubMed ID: 9287246
[TBL] [Abstract][Full Text] [Related]
56. Expression of diverse AML1/MTG8 transcripts is a consistent feature in acute myeloid leukemia with t(8;21) irrespective of disease phase.
Saunders MJ; Tobal K; Keeney S; Liu Yin JA
Leukemia; 1996 Jul; 10(7):1139-42. PubMed ID: 8683993
[TBL] [Abstract][Full Text] [Related]
57. Increased expression of AML1 during retinoic-acid-induced differentiation of U937 cells.
Tanaka K; Tanaka T; Ogawa S; Kurokawa M; Mitani K; Yazaki Y; Hirai H
Biochem Biophys Res Commun; 1995 Jun; 211(3):1023-30. PubMed ID: 7598688
[TBL] [Abstract][Full Text] [Related]
58. Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia.
Tonks A; Pearn L; Musson M; Gilkes A; Mills KI; Burnett AK; Darley RL
Leukemia; 2007 Dec; 21(12):2495-505. PubMed ID: 17898786
[TBL] [Abstract][Full Text] [Related]
59. RUNX1T1/MTG8/ETO gene expression status in human t(8;21)(q22;q22)-positive acute myeloid leukemia cells.
Migas AA; Mishkova OA; Ramanouskaya TV; Ilyushonak IM; Aleinikova OV; Grinev VV
Leuk Res; 2014 Sep; 38(9):1102-10. PubMed ID: 24976338
[TBL] [Abstract][Full Text] [Related]
60. Analysis of genes under the downstream control of the t(8;21) fusion protein AML1-MTG8: overexpression of the TIS11b (ERF-1, cMG1) gene induces myeloid cell proliferation in response to G-CSF.
Shimada H; Ichikawa H; Nakamura S; Katsu R; Iwasa M; Kitabayashi I; Ohki M
Blood; 2000 Jul; 96(2):655-63. PubMed ID: 10887131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
